Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Annals of the Rheumatic Diseases

• Publication date

  2001-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/ard.60.6.577PMID 11350846PMCID PMC1753658
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Evaluation of alveolitis by studies of lung biopsies

  2007cited by this paper
• Skin thickness score as a predictor and correlate of outcome in systemic sclerosis: high-dose versus low-dose penicillamine trial.

  2000cited by this paper
• The endothelium in the pathogenesis of systemic sclerosis: is it primary or secondary?

  1999cited by this paper
• Interferon-alpha does not improve outcome at one year in patients with diffuse cutaneous scleroderma: results of a randomized, double-blind, placebo-controlled trial.

  1999cited by this paper
• Long-term fetal microchimerism in peripheral blood mononuclear cell subsets in healthy women and women with scleroderma.

  1999cited by this paper
• Autologous haematopoietic stem cell transplants for autoimmune disease – feasibility and transplant-related mortality

  1999cited by this paper
• Prediction of five-year survival following presentation with scleroderma: development of a simple model using three disease factors at first visit.

  1999cited by this paper
• Circulating basic fibroblast growth factor declines during Cy/TBI bone marrow transplantation

  1999cited by this paper
• High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: analysis of a two-year, double-blind, randomized, controlled clinical trial.

  1999cited by this paper
• Marked and sustained improvement two years after autologous stem cell transplantation in a girl with systemic sclerosis.

  1999cited by this paper
• Systemic sclerosis-associated pulmonary hypertension: short- and long-term effects of epoprostenol (prostacyclin).

  1999cited by this paper
• HLA associations in three mutually exclusive autoantibody subgroups in UK systemic sclerosis patients.

  1998cited by this paper
• Microchimerism and HLA-compatible relationships of pregnancy in scleroderma.

  1998cited by this paper
• Hemopoietic blood and marrow transplants in the treatment of severe autoimmune disease

  1997cited by this paper
• Blood and marrow stem cell transplants in autoimmune disease. A consensus report written on behalf of the European League Against Rheumatism (EULAR) and the European Group for Blood and Marrow Transplantation (EBMT).

  1997cited by this paper
• HAEMOPOIETIC STEM CELL TRANSPLANTATION FOR AUTOIMMUNE DISEASES

  1997cited by this paper
• Skewing of the CDS + T-cell repertoire in the lungs of patients with systemic sclerosis

  1996cited by this paper
• Immunopathogenesis of systemic sclerosis.

  1996cited by this paper
• Predictive value of nailfold capillaroscopy in the diagnosis of connective tissue diseases

  1996cited by this paper
• Comparison of methotrexate with placebo in the treatment of systemic sclerosis: a 24 week randomized double-blind trial, followed by a 24 week observational trial.

  1996cited by this paper
• Skewing of the CD8+ T-cell repertoire in the lungs of patients with systemic sclerosis.

  1996cited by this paper
• Fibrosing alveolitis in systemic sclerosis: increase in memory T-cells in lung interstitium.

  1995cited by this paper
• Expansion of selected V delta 1+ gamma delta T cells in systemic sclerosis patients.

  1994cited by this paper
• Avian scleroderma: evidence for qualitative and quantitative T cell defects.

  1992cited by this paper
• Prognostic significance of anticentromere antibodies and anti-topoisomerase I antibodies in Raynaud's disease. A prospective study.

  1991cited by this paper
• Structural features of interstitial lung disease in systemic sclerosis.

  1991cited by this paper
• Selective abnormalities in the thymic microenvironment associated with avian scleroderma, an inherited fibrotic disease of L200 chickens.

  1991cited by this paper
• Identification of T cells in early dermal lymphocytic infiltrates in avian scleroderma.

  1989cited by this paper
• Lymphocytes in the skin of patients with progressive systemic sclerosis. Quantification, subtyping, and clinical correlations.

  1984cited by this paper
• The lichen planus like and sclerotic phases of the graft versus host disease in man: an ultrastructural study of six cases.

  1981cited by this paper
• Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients.

  1980cited by this paper

• Emerging Cell-Based Therapies for Systemic Sclerosis: From Stem Cells to CAR-T Cells

  2026cites this paper
• Stem cell therapy in systemic sclerosis

  2025cites this paper
• Advances in hematopoietic stem cell transplantation for autoimmune diseases

  2024cites this paper
• National diagnostic and care protocols (NDCP) for hematopoietic stem cell transplantation in autoimmune diseases.

  2024cites this paper
• High-dose chemotherapy and autologous hematopoietic stem cell transplantation for progressive systemic sclerosis: a retrospective study of outcome and prognostic factors

  2024influential citation
• Stem cell-based therapy for systemic sclerosis

  2023cites this paper
• Improvement in the clinical manifestations of interstitial lung disease following treatment with placental mesenchymal stromal cell extracellular vesicles in a patient with systemic sclerosis: A case report

  2023cites this paper
• Cardiotoxicity in autologous haematopoietic stem cell transplantation for systemic sclerosis

  2023cites this paper
• Autologous Stem Cell Transplantation with Intensity Modulated Total Body Irradiation Conditioning for Systemic Sclerosis.

  2023cites this paper
• Heterogeneity of determining disease severity, clinical course and outcomes in systemic sclerosis-associated interstitial lung disease: a systematic literature review

  2023cites this paper
• Case Report: Chemotherapy-Associated Systemic Sclerosis: Is DNA Damage to Blame?

  2022cites this paper
• A prospective observational study of mycophenolate mofetil A prospective observational study of mycophenolate mofetil treatment in progressive diffuse cutaneous systemic sclerosis of treatment in progressive diffuse cutaneous systemic sclerosis of recent onset. recent onset.

  2022cites this paper
• Myeloablative autologous haematopoietic stem cell transplantation resets the B cell repertoire to a more naïve state in patients with systemic sclerosis

  2022cites this paper
• Therapeutic Options for Systemic Sclerosis: Current and Future Perspectives in Tackling Immune-Mediated Fibrosis

  2022cites this paper
• Hematopoietic Cell Transplantation for Systemic Sclerosis—A Review

  2022cites this paper
• Stem Cell Therapy in Neuroimmunological Diseases and Its Potential Neuroimmunological Complications

  2022cites this paper
• Skin involvement in early diffuse cutaneous systemic sclerosis: an unmet clinical need

  2022cites this paper
• Advances in the Treatment of Systemic Sclerosis

  2022cites this paper
• Autologous Haematopoietic Stem Cell Transplantation and Systemic Sclerosis: Focus on Interstitial Lung Disease

  2022cites this paper
• Immune cell dysregulation as a mediator of fibrosis in systemic sclerosis

  2022cites this paper
• Reconstitution of the immune system and clinical correlates after stem cell transplantation for systemic sclerosis

  2022cites this paper
• Cellular-Based Therapies in Systemic Sclerosis: From Hematopoietic Stem Cell Transplant to Innovative Approaches

  2022influential citation
• Stem cell transplantation for systemic sclerosis.

  2022cites this paper
• Life after Autologous Hematopoietic Stem Cell Transplantation for Systemic Sclerosis

  2021cites this paper
• Hematopoietic stem cell transplantation for systemic sclerosis: Brazilian experience

  2021cites this paper
• Re-evaluating inclusion criteria for autologous hematopoietic stem cell transplantation in advanced systemic sclerosis: Three successful cases and review of the literature

  2021cites this paper
• Systemic sclerosis (scleroderma): remaining challenges

  2021influential citation
• Combining systemic and locally applied cellular therapies for the treatment of systemic sclerosis

  2021cites this paper
• A review of hematopoietic stem cell transplantation for autoimmune diseases: multiple sclerosis, systemic sclerosis and Crohn's disease. Position paper of the Brazilian Society of Bone Marrow Transplantation

  2020cites this paper
• Machine learning predicts stem cell transplant response in severe scleroderma

  2020cites this paper
• The need for a holistic approach for SSc-ILD – achievements and ambiguity in a devastating disease

  2020cites this paper
• Haematopoietic stem cell transplantation in systemic sclerosis: Challenges and perspectives.

  2020cites this paper
• Systemic sclerosis (scleroderma)

  2020cites this paper
• Stem Cell Therapies in Systemic Sclerosis: An Updated Review

  2020cites this paper
• Autologous hematopoietic stem-cell transplantation in neurological disorders: current approach and future directions

  2020cites this paper
• News and failures from recent treatment trials in systemic sclerosis.

  2020cites this paper
• Comorbidity burden in systemic sclerosis: beyond disease-specific complications

  2019cites this paper
• Application of stem cell transplantation to autoimmune diseases.

  2019cites this paper
• Cell technologies in the treatment of rheumatic diseases

  2019cites this paper
• Hematopoietic Stem Cell Transplantation Improves Functional Outcomes of Systemic Sclerosis Patients.

  2019cites this paper
• Health-related quality of life in systemic sclerosis before and after autologous haematopoietic stem cell transplant-a systematic review.

  2019cites this paper
• CD34-selected versus unmanipulated autologous haematopoietic stem cell transplantation in the treatment of severe systemic sclerosis: a post hoc analysis of a phase I/II clinical trial conducted in Japan

  2019cites this paper
• Haematopoietic stem cell transplantation in systemic sclerosis

  2018cites this paper
• Systemic Sclerosis as an Indication for Autologous Hematopoietic Cell Transplantation: Position Statement from the American Society for Blood and Marrow Transplantation.

  2018cites this paper
• Pharmacological management of progressive-fibrosing interstitial lung diseases: a review of the current evidence

  2018cites this paper
• Diagnostic criteria, severity classification and guidelines of systemic sclerosis

  2018cites this paper
• Autologous Hematopoietic Stem Cell Transplantation for Treatment of Systemic Sclerosis

  2018cites this paper
• Autolog hematopoietisk stamcelletransplantasjon (AHSCT) ved diffus systemisk sklerose

  2018cites this paper
• Stem Cell Applications for Treatment of Cancer and Autoimmune Diseases: Its Promises, Obstacles, and Future Perspectives

  2018cites this paper
• Stem cell transplant in systemic sclerosis: An Indian experience

  2018cites this paper
• Lungenfibrose bei rheumatischen Erkrankungen

  2018cites this paper
• Analyse von Anti-Topoisomerase I-Antikörpern und Evaluierung ihrer immundominanten Epitope bei Patienten mit diffus kutaner systemischer Sklerose vor und nach autologer hämatopoetischer Stammzelltransplantation

  2018cites this paper
• Efficacy and safety of autologous haematopoietic stem cell transplantation in systemic sclerosis: a systematic review of the literature

  2018cites this paper
• Myeloid-Derived Suppressor Cells and Pulmonary Hypertension

  2018cites this paper
• Myeloablative Autologous Stem‐Cell Transplantation for Severe Scleroderma

  2018cites this paper
• Autologous Hematopoietic Stem Cell Transplantation for Systemic Sclerosis: A Systematic Review and Meta-Analysis.

  2018cites this paper
• Long-term Outcomes of Autologous Peripheral Blood Stem Cell Transplantation for Refractory Rheumatic Diseases

  2017cites this paper
• The relationship between the degree of skin fibrosis by sonoelastography and the degree of pulmonary involvement in scleroderma

  2017cites this paper
• Optimization of Unrelated Donor Cord Blood Transplantation for Thalassemia: Implications for Other Non‐Malignant Indications such as HIV Infection or Autoimmune Diseases

  2017cites this paper
• Hematopoietic stem cell transplantation in autoimmune disorders: From immune-regulatory processes to clinical implications.

  2017cites this paper
• Recent advances in connective tissue disease related interstitial lung disease

  2017cites this paper
• Preoperative and Pre-transplant Cardiac Evaluation in the Cancer Patient

  2017cites this paper
• Immunomodulatory, immunoablative, and biologic therapies

  2017cites this paper
• 19 Haematopoietic Cell Transplantation and Immunotherapy for Autoimmune Diseases in Children and Adults

  2017cites this paper
• The Management of Pulmonary Arterial Hypertension in the Setting of Systemic Sclerosis

  2017cites this paper
• Adipose-Derived Mesenchymal Stem Cells in Autoimmune Disorders: State of the Art and Perspectives for Systemic Sclerosis

  2017cites this paper
• Chapter 84 – Clinical Features and Treatment of Scleroderma

  2017cites this paper
• Safety profile of autologous hematopoietic stem cell mobilization and transplantation in patients with systemic sclerosis

  2017cites this paper
• Emerging Evidence-based Therapies for Systemic Sclerosis

  2016cites this paper
• Chapter 18 – Total Body Irradiation

  2016cites this paper
• [Pulmonary fibrosis in rheumatic diseases].

  2016cites this paper
• Lungenfibrose bei rheumatischen Erkrankungen

  2016cites this paper
• BSR and BHPR guideline for the treatment of systemic sclerosis.

  2016cites this paper
• Stem cell autograft and allograft in autoimmune diseases

  2016cites this paper
• Review: Hematopoietic Stem Cell Transplantation for Scleroderma: Effective Immunomodulatory Therapy for Patients With Pulmonary Involvement

  2016cites this paper
• Does ex vivo CD34+ positive selection influence outcome after autologous hematopoietic stem cell transplantation in systemic sclerosis patients?

  2016cites this paper
• Resetting the immune response after autologous hematopoietic stem cell transplantation for autoimmune diseases.

  2016cites this paper
• Cellular Therapies in Systemic Sclerosis: Recent Progress

  2016cites this paper
• The role of autologous haemopoietic stem cell transplantation in the treatment of autoimmune disorders

  2016cites this paper
• Treatment of Diffuse Cutaneous Systemic Sclerosis with Hyperimmune Caprine Serum

  2016cites this paper
• 全身性強皮症 診断基準・重症度分類・診療ガイドライン

  2016cites this paper
• Chronic infections of the small intestine

  2015cites this paper
• Haematopoietic stem cell transplantation for poor-prognosis systemic sclerosis.

  2015cites this paper
• Hämatopoetische Stammzelltransplantation bei Autoimmunerkrankungen – Wo stehen wir aktuell?

  2015cites this paper
• Predictive value of noninvasive evaluation by exercise echocardiography and BNP measurement for early identification of pulmonary arterial hypertension in patients affected by systemic sclerosis: 5 years follow-up

  2015cites this paper
• Management of Systemic Sclerosis-Related Skin Disease: A Review of Existing and Experimental Therapeutic Approaches.

  2015cites this paper
• Stem cell therapies for systemic sclerosis

  2015cites this paper
• New insights into the pathogenesis and management of juvenile systemic sclerosis

  2015cites this paper
• Management of Systemic Sclerosis-Related Skin

  2015cites this paper
• Stem cell transplantation for systemic sclerosis

  2015cites this paper
• Stem Cells: The Future of Personalised Medicine?

  2014cites this paper
• Is immunosuppressive therapy the anchor treatment to achieve remission in systemic sclerosis?

  2014cites this paper
• Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial.

  2014cites this paper
• Cardiac assessment before stem cell transplantation for systemic sclerosis.

  2014cites this paper
• Autologous Hematopoietic Stem Cell Transplantation vs Intravenous Pulse Cyclophosphamide in Diffuse Cutaneous Systemic Sclerosis

  2014cites this paper
• Cardiac assessment before stem cell transplantation for systemic sclerosis--reply.

  2014cites this paper
• Medical Equipment Insights Stem Cells : The Future of Personalised Medicine ?

  2014cites this paper
• PREDICTIVE VALUE OF NONINVASIVE EVALUATION BY EXERCISE ECHOCARDIOGRAPHY AND BNP MEASUREMENT FOR EARLY IDENTIFICATION OF PULMONARY ARTERIAL HYPERTENSION IN PATIENTS AFFECTED BY SYSTEMIC SCLEROSIS: 5 YEARS FOLLOW-UP

  2014cites this paper
• Immunosuppression for interstitial lung disease in systemic sclerosis

  2013cites this paper
• Update on Stem Cell Transplantation for Systemic Sclerosis: Recent Trial Results

  2013cites this paper